BEDFORD, Mass.--(BUSINESS WIRE)--May 12, 2020--
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will present at the 2020 UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 at 8:20 a.m. ET.
A live audio webcast of the session may be accessed via the “Investor Relations” section of Anika’s website at www.anikatherapeutics.com. An audio archive of the session will also be available on the website.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated joint preservation and regenerative therapies company based in Bedford, Massachusetts. Anika is committed to delivering therapies to improve the lives of patients across a continuum of care from osteoarthritis pain management to joint preservation and restoration. The Company has close to three decades of global expertise commercializing more than 20 products. For more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005621/en/
For Investor Inquiries:
Anika Therapeutics, Inc.
Sylvia Cheung, 781-457-9000
Chief Financial Officer
For Media Inquiries:
Jeremy Berrington, 312-241-1995
Source: Anika Therapeutics, Inc.